More new substances recommended for approval in first half, says EMA
This article was originally published in SRA
Executive Summary
The number of medicines recommended for approval by the European Medicines Agency in the first half of 2013 rose substantially in the first half of this year compared with the 2012 period1. There was a notable increase in the tally of new active substances, of which four received a positive recommendation under special regulatory procedures for speeding up access to innovative medicines.